Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 1270Session 2025

Department of Health

S 1270 c3

Underlined text would be added to current law. Struck-through text would be removed.

Florida Senate - 2025 CS for CS for CS for SB 1270 By the Committee on Rules; the Appropriations Committee on Health and Human Services; the Committee on Health Policy; and Senator Collins 595-03811-25 20251270c3 1 A bill to be entitled 2 An act relating to the Department of Health; 3 reenacting ss. 381.00316(2)(g) and 381.00319(1)(e), 4 F.S., relating to the prohibition on discrimination by 5 governmental and business entities based on health 6 care choices and the prohibition on mask mandates and 7 vaccination and testing mandates for educational 8 institutions, respectively, for purposes of preserving 9 the definition of the term “messenger ribonucleic acid 10 vaccine” notwithstanding its scheduled repeal; 11 repealing s. 9 of chapter 2023-43, Laws of Florida, 12 which provides for the repeal of the definition of the 13 term “messenger ribonucleic acid vaccine”; amending s. 14 381.026, F.S.; revising the rights of patients, which 15 each health care provider and facility are required to 16 observe, to include that such facilities and providers 17 may not discriminate based on a patient’s vaccination 18 status; amending s. 381.986, F.S.; defining terms for 19 purposes of background screening requirements for 20 persons affiliated with medical marijuana treatment 21 centers; requiring medical marijuana treatment centers 22 to notify the Department of Health through electronic 23 mail within a specified timeframe after an actual or 24 attempted theft, diversion, or loss of marijuana; 25 requiring medical marijuana treatment centers to 26 report attempted thefts, in addition to actual thefts, 27 to law enforcement within a specified timeframe; 28 amending s. 381.988, F.S.; defining terms for purposes 29 of background screening requirements for persons 30 affiliated with medical marijuana testing 31 laboratories; amending s. 456.0145, F.S.; revising 32 eligibility criteria for licensure by endorsement 33 under the MOBILE Act; amending ss. 458.315 and 34 459.0076, F.S.; authorizing certain physician 35 assistants to be issued temporary certificates for 36 practice in areas of critical need; amending s. 37 486.112, F.S.; defining the term “party state”; 38 authorizing a remote state to issue subpoenas to 39 individuals to testify or for the production of 40 evidence from a party located in a party state; 41 providing that such subpoenas are enforceable in the 42 party state; requiring that investigative information 43 pertaining to certain licensees in a certain system be 44 available only to other party states; revising 45 construction and severability of the compact to 46 conform to changes made by the act; amending s. 47 766.1115, F.S.; revising the definition of the term 48 “health care provider” or “provider”; providing 49 effective dates. 50 51 Be It Enacted by the Legislature of the State of Florida: 52 53 Section 1. Effective upon becoming a law, or, if this act 54 fails to become a law until after June 1, 2025, operating 55 retroactively to June 1, 2025, notwithstanding the scheduled 56 repeal in section 9 of chapter 2023-43, Laws of Florida, 57 paragraph (g) of subsection (2) of section 381.00316, Florida 58 Statutes, is reenacted to read: 59 381.00316 Discrimination by governmental and business 60 entities based on health care choices; prohibition.— 61 (2) As used in this section, the term: 62 (g) “Messenger ribonucleic acid vaccine” means any vaccine 63 that uses laboratory-produced messenger ribonucleic acid to 64 trigger the human body’s immune system to generate an immune 65 response. 66 Section 2. Effective upon becoming a law, or, if this act 67 fails to become a law until after June 1, 2025, operating 68 retroactively to June 1, 2025, notwithstanding the scheduled 69 repeal in section 9 of chapter 2023-43, Laws of Florida, 70 paragraph (e) of subsection (1) of section 381.00319, Florida 71 Statutes, is reenacted to read: 72 381.00319 Prohibition on mask mandates and vaccination and 73 testing mandates for educational institutions.— 74 (1) For purposes of this section, the term: 75 (e) “Messenger ribonucleic acid vaccine” has the same 76 meaning as in s. 381.00316. 77 Section 3. Effective upon becoming a law, or, if this act 78 fails to become a law until after June 1, 2025, operating 79 retroactively to June 1, 2025, section 9 of chapter 2023-43, 80 Laws of Florida, is repealed. 81 Section 4. Paragraphs (b) and (d) of subsection (4) and 82 subsection (6) of section 381.026, Florida Statutes, are amended 83 to read: 84 381.026 Florida Patient’s Bill of Rights and 85 Responsibilities.— 86 (4) RIGHTS OF PATIENTS.—Each health care facility or 87 provider shall observe the following standards: 88 (b) Information.— 89 1. A patient has the right to know the name, function, and 90 qualifications of each health care provider who is providing 91 medical services to the patient. A patient may request such 92 information from his or her responsible provider or the health 93 care facility in which he or she is receiving medical services. 94 2. A patient in a health care facility has the right to 95 know what patient support services are available in the 96 facility. 97 3. A patient has the right to be given by his or her health 98 care provider information concerning diagnosis, planned course 99 of treatment, alternatives, risks, and prognosis, unless it is 100 medically inadvisable or impossible to give this information to 101 the patient, in which case the information must be given to the 102 patient’s guardian or a person designated as the patient’s 103 representative. A patient has the right to refuse this 104 information. 105 4. A patient has the right to refuse any treatment based on 106 information required by this paragraph, except as otherwise 107 provided by law. The responsible provider shall document any 108 such refusal. 109 5. A patient in a health care facility has the right to 110 know what facility rules and regulations apply to patient 111 conduct. 112 6. A patient has the right to express grievances to a 113 health care provider, a health care facility, or the appropriate 114 state licensing agency regarding alleged violations of patients’ 115 rights. A patient has the right to know the health care 116 provider’s or health care facility’s procedures for expressing a 117 grievance. 118 7. A patient in a health care facility who does not speak 119 English has the right to be provided an interpreter when 120 receiving medical services if the facility has a person readily 121 available who can interpret on behalf of the patient. 122 8. A health care provider or health care facility shall 123 respect a patient’s right to privacy and should refrain from 124 making a written inquiry or asking questions concerning the 125 ownership of a firearm or ammunition by the patient or by a 126 family member of the patient, or the presence of a firearm in a 127 private home or other domicile of the patient or a family member 128 of the patient. Notwithstanding this provision, a health care 129 provider or health care facility that in good faith believes 130 that this information is relevant to the patient’s medical care 131 or safety, or safety of others, may make such a verbal or 132 written inquiry. 133 9. A patient may decline to answer or provide any 134 information regarding ownership of a firearm by the patient or a 135 family member of the patient, or the presence of a firearm in 136 the domicile of the patient or a family member of the patient. A 137 patient’s decision not to answer a question relating to the 138 presence or ownership of a firearm does not alter existing law 139 regarding a physician’s authorization to choose his or her 140 patients. 141 10. A health care provider or health care facility may not 142 discriminate against a patient based solely upon the patient’s 143 exercise of the constitutional right to own and possess firearms 144 or ammunition. 145 11. A health care provider or health care facility shall 146 respect a patient’s legal right to own or possess a firearm and 147 should refrain from unnecessarily harassing a patient about 148 firearm ownership during an examination. 149 12. A health care provider or health care facility may not 150 discriminate against a patient based solely upon the patient’s 151 vaccination status. 152 (d) Access to health care.— 153 1. A patient has the right to impartial access to medical 154 treatment or accommodations, regardless of race, national 155 origin, religion, handicap, vaccination status, or source of 156 payment. 157 2. A patient has the right to treatment for any emergency 158 medical condition that will deteriorate from failure to provide 159 such treatment. 160 3. A patient has the right to access any mode of treatment 161 that is, in his or her own judgment and the judgment of his or 162 her health care practitioner, in the best interests of the 163 patient, including complementary or alternative health care 164 treatments, in accordance with the provisions of s. 456.41. 165 (6) SUMMARY OF RIGHTS AND RESPONSIBILITIES.—Any health care 166 provider who treats a patient in an office or any health care 167 facility licensed under chapter 395 that provides emergency 168 services and care or outpatient services and care to a patient, 169 or admits and treats a patient, shall adopt and make available 170 to the patient, in writing, a statement of the rights and 171 responsibilities of patients, including the following: 172 173 SUMMARY OF THE FLORIDA PATIENT’S BILL 174 OF RIGHTS AND RESPONSIBILITIES 175 176 Florida law requires that your health care 177 provider or health care facility recognize your rights 178 while you are receiving medical care and that you 179 respect the health care provider’s or health care 180 facility’s right to expect certain behavior on the 181 part of patients. You may request a copy of the full 182 text of this law from your health care provider or 183 health care facility. A summary of your rights and 184 responsibilities follows: 185 A patient has the right to be treated with 186 courtesy and respect, with appreciation of his or her 187 individual dignity, and with protection of his or her 188 need for privacy. 189 A patient has the right to a prompt and 190 reasonable response to questions and requests. 191 A patient has the right to know who is providing 192 medical services and who is responsible for his or her 193 care. 194 A patient has the right to know what patient 195 support services are available, including whether an 196 interpreter is available if he or she does not speak 197 English. 198 A patient has the right to bring any person of 199 his or her choosing to the patient-accessible areas of 200 the health care facility or provider’s office to 201 accompany the patient while the patient is receiving 202 inpatient or outpatient treatment or is consulting 203 with his or her health care provider, unless doing so 204 would risk the safety or health of the patient, other 205 patients, or staff of the facility or office or cannot 206 be reasonably accommodated by the facility or 207 provider. 208 A patient has the right to know what rules and 209 regulations apply to his or her conduct. 210 A patient has the right to be given by the health 211 care provider information concerning diagnosis, 212 planned course of treatment, alternatives, risks, and 213 prognosis. 214 A patient has the right to refuse any treatment, 215 except as otherwise provided by law. 216 A patient has the right to be given, upon 217 request, full information and necessary counseling on 218 the availability of known financial resources for his 219 or her care. 220 A patient who is eligible for Medicare has the 221 right to know, upon request and in advance of 222 treatment, whether the health care provider or health 223 care facility accepts the Medicare assignment rate. 224 A patient has the right to receive, upon request, 225 prior to treatment, a reasonable estimate of charges 226 for medical care. 227 A patient has the right to receive a copy of a 228 reasonably clear and understandable, itemized bill 229 and, upon request, to have the charges explained. 230 A patient has the right to impartial access to 231 medical treatment or accommodations, regardless of 232 race, national origin, religion, handicap, vaccination 233 status, or source of payment. 234 A patient has the right to treatment for any 235 emergency medical condition that will deteriorate from 236 failure to provide treatment. 237 A patient has the right to know if medical 238 treatment is for purposes of experimental research and 239 to give his or her consent or refusal to participate 240 in such experimental research. 241 A patient has the right to express grievances 242 regarding any violation of his or her rights, as 243 stated in Florida law, through the grievance procedure 244 of the health care provider or health care facility 245 which served him or her and to the appropriate state 246 licensing agency. 247 A patient is responsible for providing to the 248 health care provider, to the best of his or her 249 knowledge, accurate and complete information about 250 present complaints, past illnesses, hospitalizations, 251 medications, and other matters relating to his or her 252 health. 253 A patient is responsible for reporting unexpected 254 changes in his or her condition to the health care 255 provider. 256 A patient is responsible for reporting to the 257 health care provider whether he or she comprehends a 258 contemplated course of action and what is expected of 259 him or her. 260 A patient is responsible for following the 261 treatment plan recommended by the health care 262 provider. 263 A patient is responsible for keeping appointments 264 and, when he or she is unable to do so for any reason, 265 for notifying the health care provider or health care 266 facility. 267 A patient is responsible for his or her actions 268 if he or she refuses treatment or does not follow the 269 health care provider’s instructions. 270 A patient is responsible for assuring that the 271 financial obligations of his or her health care are 272 fulfilled as promptly as possible. 273 A patient is responsible for following health 274 care facility rules and regulations affecting patient 275 care and conduct. 276 277 Section 5. Paragraphs (b), (e), and (f) of subsection (8) 278 of section 381.986, Florida Statutes, are amended to read: 279 381.986 Medical use of marijuana.— 280 (8) MEDICAL MARIJUANA TREATMENT CENTERS.— 281 (b) An applicant for licensure as a medical marijuana 282 treatment center must shall apply to the department on a form 283 prescribed by the department and adopted in rule. The department 284 shall adopt rules pursuant to ss. 120.536(1) and 120.54 285 establishing a procedure for the issuance and biennial renewal 286 of licenses, including initial application and biennial renewal 287 fees sufficient to cover the costs of implementing and 288 administering this section, and establishing supplemental 289 licensure fees for payment beginning May 1, 2018, sufficient to 290 cover the costs of administering ss. 381.989 and 1004.4351. The 291 department shall identify applicants with strong diversity plans 292 reflecting this state’s commitment to diversity and implement 293 training programs and other educational programs to enable 294 minority persons and minority business enterprises, as defined 295 in s. 288.703, and veteran business enterprises, as defined in 296 s. 295.187, to compete for medical marijuana treatment center 297 licensure and contracts. Subject to the requirements in 298 subparagraphs (a)2.-4., the department shall issue a license to 299 an applicant if the applicant meets the requirements of this 300 section and pays the initial application fee. The department 301 shall renew the licensure of a medical marijuana treatment 302 center biennially if the licensee meets the requirements of this 303 section and pays the biennial renewal fee. However, the 304 department may not renew the license of a medical marijuana 305 treatment center that has not begun to cultivate, process, and 306 dispense marijuana by the date that the medical marijuana 307 treatment center is required to renew its license. An individual 308 may not be an applicant, owner, officer, board member, or 309 manager on more than one application for licensure as a medical 310 marijuana treatment center. An individual or entity may not be 311 awarded more than one license as a medical marijuana treatment 312 center. An applicant for licensure as a medical marijuana 313 treatment center must demonstrate: 314 1. That, for the 5 consecutive years before submitting the 315 application, the applicant has been registered to do business in 316 this the state. 317 2. Possession of a valid certificate of registration issued 318 by the Department of Agriculture and Consumer Services pursuant 319 to s. 581.131. 320 3. The technical and technological ability to cultivate and 321 produce marijuana, including, but not limited to, low-THC 322 cannabis. 323 4. The ability to secure the premises, resources, and 324 personnel necessary to operate as a medical marijuana treatment 325 center. 326 5. The ability to maintain accountability of all raw 327 materials, finished products, and any byproducts to prevent 328 diversion or unlawful access to or possession of these 329 substances. 330 6. An infrastructure reasonably located to dispense 331 marijuana to registered qualified patients statewide or 332 regionally as determined by the department. 333 7. The financial ability to maintain operations for the 334 duration of the 2-year approval cycle, including the provision 335 of certified financial statements to the department. 336 a. Upon approval, the applicant must post a $5 million 337 performance bond issued by an authorized surety insurance 338 company rated in one of the three highest rating categories by a 339 nationally recognized rating service. However, a medical 340 marijuana treatment center serving at least 1,000 qualified 341 patients is only required to maintain a $2 million performance 342 bond. 343 b. In lieu of the performance bond required under sub 344 subparagraph a., the applicant may provide an irrevocable letter 345 of credit payable to the department or provide cash to the 346 department. If provided with cash under this sub-subparagraph, 347 the department must shall deposit the cash in the Grants and 348 Donations Trust Fund within the Department of Health, subject to 349 the same conditions as the bond regarding requirements for the 350 applicant to forfeit ownership of the funds. If the funds 351 deposited under this sub-subparagraph generate interest, the 352 amount of that interest must shall be used by the department for 353 the administration of this section. 354 8. That all owners, officers, board members, and managers 355 have passed a background screening pursuant to subsection (9). 356 As used in this subparagraph, the term: 357 a. “Manager” means any person with the authority to 358 exercise or contribute to the operational control, direction, or 359 management of an applicant or a medical marijuana treatment 360 center or who has authority to supervise any employee of an 361 applicant or a medical marijuana treatment center. The term 362 includes an individual with the power or authority to direct or 363 influence the direction or operation of an applicant or a 364 medical marijuana treatment center through board membership, an 365 agreement, or a contract. 366 b. “Owner” means any person who owns or controls a 5 367 percent or greater share of interests of the applicant or a 368 medical marijuana treatment center which include beneficial or 369 voting rights to interests. In the event that one person owns a 370 beneficial right to interests and another person holds the 371 voting rights with respect to such interests, then in such case, 372 both are considered the owner of such interests. 373 9. The employment of a medical director to supervise the 374 activities of the medical marijuana treatment center. 375 10. A diversity plan that promotes and ensures the 376 involvement of minority persons and minority business 377 enterprises, as defined in s. 288.703, or veteran business 378 enterprises, as defined in s. 295.187, in ownership, management, 379 and employment. An applicant for licensure renewal must show the 380 effectiveness of the diversity plan by including the following 381 with his or her application for renewal: 382 a. Representation of minority persons and veterans in the 383 medical marijuana treatment center’s workforce; 384 b. Efforts to recruit minority persons and veterans for 385 employment; and 386 c. A record of contracts for services with minority 387 business enterprises and veteran business enterprises. 388 (e) A licensed medical marijuana treatment center shall 389 cultivate, process, transport, and dispense marijuana for 390 medical use. A licensed medical marijuana treatment center may 391 not contract for services directly related to the cultivation, 392 processing, and dispensing of marijuana or marijuana delivery 393 devices, except that a medical marijuana treatment center 394 licensed pursuant to subparagraph (a)1. may contract with a 395 single entity for the cultivation, processing, transporting, and 396 dispensing of marijuana and marijuana delivery devices. A 397 licensed medical marijuana treatment center shall must, at all 398 times, maintain compliance with the criteria demonstrated and 399 representations made in the initial application and the criteria 400 established in this subsection. Upon request, the department may 401 grant a medical marijuana treatment center a variance from the 402 representations made in the initial application. Consideration 403 of such a request must shall be based upon the individual facts 404 and circumstances surrounding the request. A variance may not be 405 granted unless the requesting medical marijuana treatment center 406 can demonstrate to the department that it has a proposed 407 alternative to the specific representation made in its 408 application which fulfills the same or a similar purpose as the 409 specific representation in a way that the department can 410 reasonably determine will not be a lower standard than the 411 specific representation in the application. A variance may not 412 be granted from the requirements in subparagraph 2. and 413 subparagraphs (b)1. and 2. 414 1. A licensed medical marijuana treatment center may 415 transfer ownership to an individual or entity who meets the 416 requirements of this section. A publicly traded corporation or 417 publicly traded company that meets the requirements of this 418 section is not precluded from ownership of a medical marijuana 419 treatment center. To accommodate a change in ownership: 420 a. The licensed medical marijuana treatment center shall 421 notify the department in writing at least 60 days before the 422 anticipated date of the change of ownership. 423 b. The individual or entity applying for initial licensure 424 due to a change of ownership must submit an application that 425 must be received by the department at least 60 days before the 426 date of change of ownership. 427 c. Upon receipt of an application for a license, the 428 department shall examine the application and, within 30 days 429 after receipt, notify the applicant in writing of any apparent 430 errors or omissions and request any additional information 431 required. 432 d. Requested information omitted from an application for 433 licensure must be filed with the department within 21 days after 434 the department’s request for omitted information or the 435 application will shall be deemed incomplete and shall be 436 withdrawn from further consideration and the fees shall be 437 forfeited. 438 e. Within 30 days after the receipt of a complete 439 application, the department shall approve or deny the 440 application. 441 2. A medical marijuana treatment center, and any individual 442 or entity who directly or indirectly owns, controls, or holds 443 with power to vote 5 percent or more of the voting shares of a 444 medical marijuana treatment center, may not acquire direct or 445 indirect ownership or control of any voting shares or other form 446 of ownership of any other medical marijuana treatment center. 447 3. A medical marijuana treatment center may not enter into 448 any form of profit-sharing arrangement with the property owner 449 or lessor of any of its facilities where cultivation, 450 processing, storing, or dispensing of marijuana and marijuana 451 delivery devices occurs. 452 4. All employees of a medical marijuana treatment center 453 must be 21 years of age or older and have passed a background 454 screening pursuant to subsection (9). As used in this 455 subparagraph, the term “employee” means any person employed by a 456 medical marijuana treatment center licensee in any capacity, 457 including those whose duties involve any aspect of the 458 cultivation, processing, transportation, or dispensing of 459 marijuana. This requirement applies to all employees, regardless 460 of the compensation received. 461 5. Each medical marijuana treatment center must adopt and 462 enforce policies and procedures to ensure employees and 463 volunteers receive training on the legal requirements to 464 dispense marijuana to qualified patients. 465 6. When growing marijuana, a medical marijuana treatment 466 center: 467 a. May use pesticides determined by the department, after 468 consultation with the Department of Agriculture and Consumer 469 Services, to be safely applied to plants intended for human 470 consumption, but may not use pesticides designated as 471 restricted-use pesticides pursuant to s. 487.042. 472 b. Must grow marijuana within an enclosed structure and in 473 a room separate from any other plant. 474 c. Must inspect seeds and growing plants for plant pests 475 that endanger or threaten the horticultural and agricultural 476 interests of the state in accordance with chapter 581 and any 477 rules adopted thereunder. 478 d. Must perform fumigation or treatment of plants, or 479 remove and destroy infested or infected plants, in accordance 480 with chapter 581 and any rules adopted thereunder. 481 7. Each medical marijuana treatment center must produce and 482 make available for purchase at least one low-THC cannabis 483 product. 484 8. A medical marijuana treatment center that produces 485 edibles must hold a permit to operate as a food establishment 486 pursuant to chapter 500, the Florida Food Safety Act, and must 487 comply with all the requirements for food establishments 488 pursuant to chapter 500 and any rules adopted thereunder. 489 Edibles may not contain more than 200 milligrams of 490 tetrahydrocannabinol, and a single serving portion of an edible 491 may not exceed 10 milligrams of tetrahydrocannabinol. Edibles 492 may not have a potency variance of no greater than 15 percent. 493 Marijuana products, including edibles, may not be attractive to 494 children; be manufactured in the shape of humans, cartoons, or 495 animals; be manufactured in a form that bears any reasonable 496 resemblance to products available for consumption as 497 commercially available candy; or contain any color additives. To 498 discourage consumption of edibles by children, the department 499 shall determine by rule any shapes, forms, and ingredients 500 allowed and prohibited for edibles. Medical marijuana treatment 501 centers may not begin processing or dispensing edibles until 502 after the effective date of the rule. The department shall also 503 adopt sanitation rules providing the standards and requirements 504 for the storage, display, or dispensing of edibles. 505 9. Within 12 months after licensure, a medical marijuana 506 treatment center must demonstrate to the department that all of 507 its processing facilities have passed a Food Safety Good 508 Manufacturing Practices, such as Global Food Safety Initiative 509 or equivalent, inspection by a nationally accredited certifying 510 body. A medical marijuana treatment center must immediately stop 511 processing at any facility which fails to pass this inspection 512 until it demonstrates to the department that such facility has 513 met this requirement. 514 10. A medical marijuana treatment center that produces 515 prerolled marijuana cigarettes may not use wrapping paper made 516 with tobacco or hemp. 517 11. When processing marijuana, a medical marijuana 518 treatment center must: 519 a. Process the marijuana within an enclosed structure and 520 in a room separate from other plants or products. 521 b. Comply with department rules when processing marijuana 522 with hydrocarbon solvents or other solvents or gases exhibiting 523 potential toxicity to humans. The department shall determine by 524 rule the requirements for medical marijuana treatment centers to 525 use such solvents or gases exhibiting potential toxicity to 526 humans. 527 c. Comply with federal and state laws and regulations and 528 department rules for solid and liquid wastes. The department 529 shall determine by rule procedures for the storage, handling, 530 transportation, management, and disposal of solid and liquid 531 waste generated during marijuana production and processing. The 532 Department of Environmental Protection shall assist the 533 department in developing such rules. 534 d. Test the processed marijuana using a medical marijuana 535 testing laboratory before it is dispensed. Results must be 536 verified and signed by two medical marijuana treatment center 537 employees. Before dispensing, the medical marijuana treatment 538 center must determine that the test results indicate that low 539 THC cannabis meets the definition of low-THC cannabis, the 540 concentration of tetrahydrocannabinol meets the potency 541 requirements of this section, the labeling of the concentration 542 of tetrahydrocannabinol and cannabidiol is accurate, and all 543 marijuana is safe for human consumption and free from 544 contaminants that are unsafe for human consumption. The 545 department shall determine by rule which contaminants must be 546 tested for and the maximum levels of each contaminant which are 547 safe for human consumption. The Department of Agriculture and 548 Consumer Services shall assist the department in developing the 549 testing requirements for contaminants that are unsafe for human 550 consumption in edibles. The department shall also determine by 551 rule the procedures for the treatment of marijuana that fails to 552 meet the testing requirements of this section, s. 381.988, or 553 department rule. The department may select samples of marijuana 554 from a medical marijuana treatment center facility which shall 555 be tested by the department to determine whether the marijuana 556 meets the potency requirements of this section, is safe for 557 human consumption, and is accurately labeled with the 558 tetrahydrocannabinol and cannabidiol concentration or to verify 559 the result of marijuana testing conducted by a marijuana testing 560 laboratory. The department may also select samples of marijuana 561 delivery devices from a medical marijuana treatment center to 562 determine whether the marijuana delivery device is safe for use 563 by qualified patients. A medical marijuana treatment center may 564 not require payment from the department for the sample. A 565 medical marijuana treatment center must recall marijuana, 566 including all marijuana and marijuana products made from the 567 same batch of marijuana, that fails to meet the potency 568 requirements of this section, that is unsafe for human 569 consumption, or for which the labeling of the 570 tetrahydrocannabinol and cannabidiol concentration is 571 inaccurate. The department shall adopt rules to establish 572 marijuana potency variations of no greater than 15 percent using 573 negotiated rulemaking pursuant to s. 120.54(2)(d) which accounts 574 for, but is not limited to, time lapses between testing, testing 575 methods, testing instruments, and types of marijuana sampled for 576 testing. The department may not issue any recalls for product 577 potency as it relates to product labeling before issuing a rule 578 relating to potency variation standards. A medical marijuana 579 treatment center must also recall all marijuana delivery devices 580 determined to be unsafe for use by qualified patients. The 581 medical marijuana treatment center must retain records of all 582 testing and samples of each homogeneous batch of marijuana for 583 at least 9 months. The medical marijuana treatment center must 584 contract with a marijuana testing laboratory to perform audits 585 on the medical marijuana treatment center’s standard operating 586 procedures, testing records, and samples and provide the results 587 to the department to confirm that the marijuana or low-THC 588 cannabis meets the requirements of this section and that the 589 marijuana or low-THC cannabis is safe for human consumption. A 590 medical marijuana treatment center shall reserve two processed 591 samples from each batch and retain such samples for at least 9 592 months for the purpose of such audits. A medical marijuana 593 treatment center may use a laboratory that has not been 594 certified by the department under s. 381.988 until such time as 595 at least one laboratory holds the required certification, but in 596 no event later than July 1, 2018. 597 e. Package the marijuana in compliance with the United 598 States Poison Prevention Packaging Act of 1970, 15 U.S.C. ss. 599 1471 et seq. 600 f. Package the marijuana in a receptacle that has a firmly 601 affixed and legible label stating the following information: 602 (I) The marijuana or low-THC cannabis meets the 603 requirements of sub-subparagraph d. 604 (II) The name of the medical marijuana treatment center 605 from which the marijuana originates. 606 (III) The batch number and harvest number from which the 607 marijuana originates and the date dispensed. 608 (IV) The name of the physician who issued the physician 609 certification. 610 (V) The name of the patient. 611 (VI) The product name, if applicable, and dosage form, 612 including concentration of tetrahydrocannabinol and cannabidiol. 613 The product name may not contain wording commonly associated 614 with products that are attractive to children or which promote 615 the recreational use of marijuana. 616 (VII) The recommended dose. 617 (VIII) A warning that it is illegal to transfer medical 618 marijuana to another person. 619 (IX) A marijuana universal symbol developed by the 620 department. 621 12. The medical marijuana treatment center shall include in 622 each package a patient package insert with information on the 623 specific product dispensed related to: 624 a. Clinical pharmacology. 625 b. Indications and use. 626 c. Dosage and administration. 627 d. Dosage forms and strengths. 628 e. Contraindications. 629 f. Warnings and precautions. 630 g. Adverse reactions. 631 13. In addition to the packaging and labeling requirements 632 specified in subparagraphs 11. and 12., marijuana in a form for 633 smoking must be packaged in a sealed receptacle with a legible 634 and prominent warning to keep away from children and a warning 635 that states marijuana smoke contains carcinogens and may 636 negatively affect health. Such receptacles for marijuana in a 637 form for smoking must be plain, opaque, and white without 638 depictions of the product or images other than the medical 639 marijuana treatment center’s department-approved logo and the 640 marijuana universal symbol. 641 14. The department shall adopt rules to regulate the types, 642 appearance, and labeling of marijuana delivery devices dispensed 643 from a medical marijuana treatment center. The rules must 644 require marijuana delivery devices to have an appearance 645 consistent with medical use. 646 15. Each edible must be individually sealed in plain, 647 opaque wrapping marked only with the marijuana universal symbol. 648 Where practical, each edible must be marked with the marijuana 649 universal symbol. In addition to the packaging and labeling 650 requirements in subparagraphs 11. and 12., edible receptacles 651 must be plain, opaque, and white without depictions of the 652 product or images other than the medical marijuana treatment 653 center’s department-approved logo and the marijuana universal 654 symbol. The receptacle must also include a list of all the 655 edible’s ingredients, storage instructions, an expiration date, 656 a legible and prominent warning to keep away from children and 657 pets, and a warning that the edible has not been produced or 658 inspected pursuant to federal food safety laws. 659 16. When dispensing marijuana or a marijuana delivery 660 device, a medical marijuana treatment center: 661 a. May dispense any active, valid order for low-THC 662 cannabis, medical cannabis and cannabis delivery devices issued 663 pursuant to former s. 381.986, Florida Statutes 2016, which was 664 entered into the medical marijuana use registry before July 1, 665 2017. 666 b. May not dispense more than a 70-day supply of marijuana 667 within any 70-day period to a qualified patient or caregiver. 668 May not dispense more than one 35-day supply of marijuana in a 669 form for smoking within any 35-day period to a qualified patient 670 or caregiver. A 35-day supply of marijuana in a form for smoking 671 may not exceed 2.5 ounces unless an exception to this amount is 672 approved by the department pursuant to paragraph (4)(f). 673 c. Must have the medical marijuana treatment center’s 674 employee who dispenses the marijuana or a marijuana delivery 675 device enter into the medical marijuana use registry his or her 676 name or unique employee identifier. 677 d. Must verify that the qualified patient and the 678 caregiver, if applicable, each have an active registration in 679 the medical marijuana use registry and an active and valid 680 medical marijuana use registry identification card, the amount 681 and type of marijuana dispensed matches the physician 682 certification in the medical marijuana use registry for that 683 qualified patient, and the physician certification has not 684 already been filled. 685 e. May not dispense marijuana to a qualified patient who is 686 younger than 18 years of age. If the qualified patient is 687 younger than 18 years of age, marijuana may only be dispensed to 688 the qualified patient’s caregiver. 689 f. May not dispense or sell any other type of cannabis, 690 alcohol, or illicit drug-related product, including pipes or 691 wrapping papers made with tobacco or hemp, other than a 692 marijuana delivery device required for the medical use of 693 marijuana and which is specified in a physician certification. 694 g. Must, upon dispensing the marijuana or marijuana 695 delivery device, record in the registry the date, time, 696 quantity, and form of marijuana dispensed; the type of marijuana 697 delivery device dispensed; and the name and medical marijuana 698 use registry identification number of the qualified patient or 699 caregiver to whom the marijuana delivery device was dispensed. 700 h. Must ensure that patient records are not visible to 701 anyone other than the qualified patient, his or her caregiver, 702 and authorized medical marijuana treatment center employees. 703 (f) To ensure the safety and security of premises where the 704 cultivation, processing, storing, or dispensing of marijuana 705 occurs, and to maintain adequate controls against the diversion, 706 theft, and loss of marijuana or marijuana delivery devices, a 707 medical marijuana treatment center shall: 708 1.a. Maintain a fully operational security alarm system 709 that secures all entry points and perimeter windows and is 710 equipped with motion detectors; pressure switches; and duress, 711 panic, and hold-up alarms; and 712 b. Maintain a video surveillance system that records 713 continuously 24 hours a day and meets the following criteria: 714 (I) Cameras are fixed in a place that allows for the clear 715 identification of persons and activities in controlled areas of 716 the premises. Controlled areas include grow rooms, processing 717 rooms, storage rooms, disposal rooms or areas, and point-of-sale 718 rooms. 719 (II) Cameras are fixed in entrances and exits to the 720 premises, which must shall record from both indoor and outdoor, 721 or ingress and egress, vantage points. 722 (III) Recorded images must clearly and accurately display 723 the time and date. 724 (IV) Retain video surveillance recordings for at least 45 725 days or longer upon the request of a law enforcement agency. 726 2. Ensure that the medical marijuana treatment center’s 727 outdoor premises have sufficient lighting from dusk until dawn. 728 3. Ensure that the indoor premises where dispensing occurs 729 includes a waiting area with sufficient space and seating to 730 accommodate qualified patients and caregivers and at least one 731 private consultation area that is isolated from the waiting area 732 and area where dispensing occurs. A medical marijuana treatment 733 center may not display products or dispense marijuana or 734 marijuana delivery devices in the waiting area. 735 4. Not dispense from its premises marijuana or a marijuana 736 delivery device between the hours of 9 p.m. and 7 a.m., but may 737 perform all other operations and deliver marijuana to qualified 738 patients 24 hours a day. 739 5. Store marijuana in a secured, locked room or a vault. 740 6. Require at least two of its employees, or two employees 741 of a security agency with whom it contracts, to be on the 742 premises at all times where cultivation, processing, or storing 743 of marijuana occurs. 744 7. Require each employee or contractor to wear a photo 745 identification badge at all times while on the premises. 746 8. Require each visitor to wear a visitor pass at all times 747 while on the premises. 748 9. Implement an alcohol and drug-free workplace policy. 749 10. Report to local law enforcement and notify the 750 department through e-mail within 24 hours after the medical 751 marijuana treatment center is notified or becomes aware of any 752 actual or attempted the theft, diversion, or loss of marijuana. 753 Section 6. Paragraph (d) of subsection (1) of section 754 381.988, Florida Statutes, is amended to read: 755 381.988 Medical marijuana testing laboratories; marijuana 756 tests conducted by a certified laboratory.— 757 (1) A person or entity seeking to be a certified marijuana 758 testing laboratory must: 759 (d) Require all employees, owners, and managers to submit 760 to and pass a level 2 background screening pursuant to chapter 761 435. The department shall deny certification if the person or 762 entity seeking certification has a disqualifying offense as 763 provided in s. 435.04 or has an arrest awaiting final 764 disposition for, has been found guilty of, or has entered a plea 765 of guilty or nolo contendere to, regardless of adjudication, any 766 offense listed in chapter 837, chapter 895, or chapter 896 or 767 similar law of another jurisdiction. Exemptions from 768 disqualification as provided under s. 435.07 do not apply to 769 this paragraph. 770 1. As used in this paragraph, the term: 771 a. “Employee” means any person whose duties or activities 772 involve any aspect of regulatory compliance testing or research 773 and development testing of marijuana for a certified marijuana 774 testing laboratory, regardless of whether such person is 775 compensated for his or her work. 776 b. “Manager” means any person with authority to exercise or 777 contribute to the operational control, direction, or management 778 of an applicant or certified marijuana testing laboratory or who 779 has authority to supervise any employee of an applicant or a 780 certified marijuana testing laboratory. The term includes an 781 individual with the power or authority to direct or influence 782 the direction or operation of an applicant or a certified 783 marijuana testing laboratory through board membership, an 784 agreement, or a contract. 785 c. “Owner” means any person who owns or controls a 5 786 percent or greater share of interests of the applicant or a 787 certified marijuana testing laboratory which include beneficial 788 or voting rights to interests. In the event that one person owns 789 a beneficial right to interests and another person holds the 790 voting rights with respect to such interests, then in such case, 791 both are considered the owner of such interests. 792 2. Such employees, owners, and managers must submit a full 793 set of fingerprints to the department or to a vendor, entity, or 794 agency authorized by s. 943.053(13). The department, vendor, 795 entity, or agency shall forward the fingerprints to the 796 Department of Law Enforcement for state processing, and the 797 Department of Law Enforcement shall forward the fingerprints to 798 the Federal Bureau of Investigation for national processing. 799 3.2. Fees for state and federal fingerprint processing and 800 retention must shall be borne by the certified marijuana testing 801 laboratory. The state cost for fingerprint processing is shall 802 be as provided in s. 943.053(3)(e) for records provided to 803 persons or entities other than those specified as exceptions 804 therein. 805 4.3. Fingerprints submitted to the Department of Law 806 Enforcement pursuant to this paragraph must shall be retained by 807 the Department of Law Enforcement as provided in s. 943.05(2)(g) 808 and (h) and, when the Department of Law Enforcement begins 809 participation in the program, enrolled in the Federal Bureau of 810 Investigation’s national retained print arrest notification 811 program. Any arrest record identified must shall be reported to 812 the department. 813 Section 7. Paragraph (c) of subsection (2) of section 814 456.0145, Florida Statutes, is amended to read: 815 456.0145 Mobile Opportunity by Interstate Licensure 816 Endorsement (MOBILE) Act.— 817 (2) LICENSURE BY ENDORSEMENT.— 818 (c) A person is ineligible for a license under this section 819 if he or she: 820 1. Has a complaint, an allegation, or an investigation 821 pending before a licensing entity in another state, the District 822 of Columbia, or a possession or territory of the United States; 823 2. Has been convicted of or pled nolo contendere to, 824 regardless of adjudication, any felony or misdemeanor related to 825 the practice of a health care profession; 826 3. Has had a health care provider license revoked or 827 suspended by another state, the District of Columbia, or a 828 territory of the United States, or has voluntarily surrendered 829 any such license in lieu of having disciplinary action taken 830 against the license; or 831 4. Has been reported to the National Practitioner Data 832 Bank, unless the applicant has successfully appealed to have his 833 or her name removed from the data bank. If the reported adverse 834 action was a result of conduct that would not constitute a 835 violation of any law or rule in this state, the board, or the 836 department if there is no board, may: 837 a. Approve the application; 838 b. Approve the application with restrictions on the scope 839 of practice of the licensee; 840 c. Approve the application with placement of the licensee 841 on probation for a period of time and subject to such conditions 842 as the board, or the department if there is no board, may 843 specify, including, but not limited to, requiring the applicant 844 to submit to treatment, attend continuing education courses, or 845 submit to reexamination; or 846 d. Deny the application. 847 Section 8. Subsection (1) of section 458.315, Florida 848 Statutes, is amended to read: 849 458.315 Temporary certificate for practice in areas of 850 critical need.— 851 (1) A physician or physician assistant who is licensed to 852 practice in any jurisdiction of the United States and whose 853 license is currently valid may be issued a temporary certificate 854 for practice in areas of critical need. A physician seeking such 855 certificate must pay an application fee of $300. A physician 856 assistant licensed to practice in any state of the United States 857 or the District of Columbia whose license is currently valid may 858 be issued a temporary certificate for practice in areas of 859 critical need. 860 Section 9. Subsection (1) of section 459.0076, Florida 861 Statutes, is amended to read: 862 459.0076 Temporary certificate for practice in areas of 863 critical need.— 864 (1) A physician or physician assistant who holds a valid 865 license to practice in any jurisdiction of the United States may 866 be issued a temporary certificate for practice in areas of 867 critical need. A physician seeking such certificate must pay an 868 application fee of $300. A physician assistant licensed to 869 practice in any state of the United States or the District of 870 Columbia whose license is currently valid may be issued a 871 temporary certificate for practice in areas of critical need. 872 Section 10. Section 486.112, Florida Statutes, is amended 873 to read: 874 486.112 Physical Therapy Licensure Compact.—The Physical 875 Therapy Licensure Compact is hereby enacted into law and entered 876 into by this state with all other jurisdictions legally joining 877 therein in the form substantially as follows: 878 879 ARTICLE I 880 PURPOSE AND OBJECTIVES 881 882 (1) The purpose of the compact is to facilitate interstate 883 practice of physical therapy with the goal of improving public 884 access to physical therapy services. The compact preserves the 885 regulatory authority of member states to protect public health 886 and safety through their current systems of state licensure. For 887 purposes of state regulation under the compact, the practice of 888 physical therapy is deemed to have occurred in the state where 889 the patient is located at the time physical therapy is provided 890 to the patient. 891 (2) The compact is designed to achieve all of the following 892 objectives: 893 (a) Increase public access to physical therapy services by 894 providing for the mutual recognition of other member state 895 licenses. 896 (b) Enhance the states’ ability to protect the public’s 897 health and safety. 898 (c) Encourage the cooperation of member states in 899 regulating multistate physical therapy practice. 900 (d) Support spouses of relocating military members. 901 (e) Enhance the exchange of licensure, investigative, and 902 disciplinary information between member states. 903 (f) Allow a remote state to hold a provider of services 904 with a compact privilege in that state accountable to that 905 state’s practice standards. 906 907 ARTICLE II 908 DEFINITIONS 909 910 As used in the compact, and except as otherwise provided, 911 the term: 912 (1) “Active duty military” means full-time duty status in 913 the active uniformed service of the United States, including 914 members of the National Guard and Reserve on active duty orders 915 pursuant to 10 U.S.C. chapter 1209 or chapter 1211. 916 (2) “Adverse action” means disciplinary action taken by a 917 physical therapy licensing board based upon misconduct, 918 unacceptable performance, or a combination of both. 919 (3) “Alternative program” means a nondisciplinary 920 monitoring or practice remediation process approved by a state’s 921 physical therapy licensing board. The term includes, but is not 922 limited to, programs that address substance abuse issues. 923 (4) “Compact privilege” means the authorization granted by 924 a remote state to allow a licensee from another member state to 925 practice as a physical therapist or physical therapist assistant 926 in the remote state under its laws and rules. 927 (5) “Continuing competence” means a requirement, as a 928 condition of license renewal, to provide evidence of 929 participation in, and completion of, educational and 930 professional activities relevant to the practice of physical 931 therapy. 932 (6) “Data system” means the coordinated database and 933 reporting system created by the Physical Therapy Compact 934 Commission for the exchange of information between member states 935 relating to licensees or applicants under the compact, including 936 identifying information, licensure data, investigative 937 information, adverse actions, nonconfidential information 938 related to alternative program participation, any denials of 939 applications for licensure, and other information as specified 940 by commission rule. 941 (7) “Encumbered license” means a license that a physical 942 therapy licensing board has limited in any way. 943 (8) “Executive board” means a group of directors elected or 944 appointed to act on behalf of, and within the powers granted to 945 them by, the commission. 946 (9) “Home state” means the member state that is the 947 licensee’s primary state of residence. 948 (10) “Investigative information” means information, 949 records, and documents received or generated by a physical 950 therapy licensing board pursuant to an investigation. 951 (11) “Jurisprudence requirement” means the assessment of an 952 individual’s knowledge of the laws and rules governing the 953 practice of physical therapy in a specific state. 954 (12) “Licensee” means an individual who currently holds an 955 authorization from a state to practice as a physical therapist 956 or physical therapist assistant. 957 (13) “Member state” means a state that has enacted the 958 compact. 959 (14) “Party state” means any member state in which a 960 licensee holds a current license or compact privilege or is 961 applying for a license or compact privilege. 962 (15) “Physical therapist” means an individual licensed by a 963 state to practice physical therapy. 964 (16)(15) “Physical therapist assistant” means an individual 965 licensed by a state to assist a physical therapist in specified 966 areas of physical therapy. 967 (17)(16) “Physical therapy” or “the practice of physical 968 therapy” means the care and services provided by or under the 969 direction and supervision of a licensed physical therapist. 970 (18)(17) “Physical Therapy Compact Commission” or 971 “commission” means the national administrative body whose 972 membership consists of all states that have enacted the compact. 973 (19)(18) “Physical therapy licensing board” means the 974 agency of a state which is responsible for the licensing and 975 regulation of physical therapists and physical therapist 976 assistants. 977 (20)(19) “Remote state” means a member state other than the 978 home state where a licensee is exercising or seeking to exercise 979 the compact privilege. 980 (21)(20) “Rule” means a regulation, principle, or directive 981 adopted by the commission which has the force of law. 982 (22)(21) “State” means any state, commonwealth, district, 983 or territory of the United States of America which regulates the 984 practice of physical therapy. 985 986 ARTICLE III 987 STATE PARTICIPATION IN THE COMPACT 988 989 (1) To participate in the compact, a state must do all of 990 the following: 991 (a) Participate fully in the commission’s data system, 992 including using the commission’s unique identifier, as defined 993 by commission rule. 994 (b) Have a mechanism in place for receiving and 995 investigating complaints about licensees. 996 (c) Notify the commission, in accordance with the terms of 997 the compact and rules, of any adverse action or the availability 998 of investigative information regarding a licensee. 999 (d) Fully implement a criminal background check 1000 requirement, within a timeframe established by commission rule, 1001 which uses results from the Federal Bureau of Investigation 1002 record search on criminal background checks to make licensure 1003 decisions in accordance with subsection (2). 1004 (e) Comply with the commission’s rules. 1005 (f) Use a recognized national examination as a requirement 1006 for licensure pursuant to the commission’s rules. 1007 (g) Have continuing competence requirements as a condition 1008 for license renewal. 1009 (2) Upon adoption of the compact, a member state has the 1010 authority to obtain biometric-based information from each 1011 licensee applying for a compact privilege and submit this 1012 information to the Federal Bureau of Investigation for a 1013 criminal background check in accordance with 28 U.S.C. s. 534 1014 and 34 U.S.C. s. 40316. 1015 (3) A member state must grant the compact privilege to a 1016 licensee holding a valid unencumbered license in another member 1017 state in accordance with the terms of the compact and rules. 1018 1019 ARTICLE IV 1020 COMPACT PRIVILEGE 1021 1022 (1) To exercise the compact privilege under the compact, a 1023 licensee must satisfy all of the following conditions: 1024 (a) Hold a license in the home state. 1025 (b) Not have an encumbrance on any state license. 1026 (c) Be eligible for a compact privilege in all member 1027 states in accordance with subsections (4), (7), and (8). 1028 (d) Not have had an adverse action against any license or 1029 compact privilege within the preceding 2 years. 1030 (e) Notify the commission that the licensee is seeking the 1031 compact privilege within a remote state. 1032 (f) Meet any jurisprudence requirements established by the 1033 remote state in which the licensee is seeking a compact 1034 privilege. 1035 (g) Report to the commission adverse action taken by any 1036 nonmember state within 30 days after the date the adverse action 1037 is taken. 1038 (2) The compact privilege is valid until the expiration 1039 date of the home license. The licensee must continue to meet the 1040 requirements of subsection (1) to maintain the compact privilege 1041 in a remote state. 1042 (3) A licensee providing physical therapy in a remote state 1043 under the compact privilege must comply with the laws and rules 1044 of the remote state. 1045 (4) A licensee providing physical therapy in a remote state 1046 is subject to that state’s regulatory authority. A remote state 1047 may, in accordance with due process and that state’s laws, 1048 remove a licensee’s compact privilege in the remote state for a 1049 specific period of time, impose fines, and take any other 1050 necessary actions to protect the health and safety of its 1051 citizens. The licensee is not eligible for a compact privilege 1052 in any member state until the specific period of time for 1053 removal has ended and all fines are paid. 1054 (5) If a home state license is encumbered, the licensee 1055 loses the compact privilege in any remote state until the 1056 following conditions are met: 1057 (a) The home state license is no longer encumbered. 1058 (b) Two years have elapsed from the date of the adverse 1059 action. 1060 (6) Once an encumbered license in the home state is 1061 restored to good standing, the licensee must meet the 1062 requirements of subsection (1) to obtain a compact privilege in 1063 any remote state. 1064 (7) If a licensee’s compact privilege in any remote state 1065 is removed, the licensee loses the compact privilege in all 1066 remote states until all of the following conditions are met: 1067 (a) The specific period of time for which the compact 1068 privilege was removed has ended. 1069 (b) All fines have been paid. 1070 (c) Two years have elapsed from the date of the adverse 1071 action. 1072 (8) Once the requirements of subsection (7) have been met, 1073 the licensee must meet the requirements of subsection (1) to 1074 obtain a compact privilege in a remote state. 1075 1076 ARTICLE V 1077 ACTIVE DUTY MILITARY PERSONNEL 1078 AND THEIR SPOUSES 1079 1080 A licensee who is active duty military or is the spouse of 1081 an individual who is active duty military may choose any of the 1082 following locations to designate his or her home state: 1083 (1) Home of record. 1084 (2) Permanent change of station location. 1085 (3) State of current residence, if it is different from the 1086 home of record or permanent change of station location. 1087 1088 ARTICLE VI 1089 ADVERSE ACTIONS 1090 1091 (1) A home state has exclusive power to impose adverse 1092 action against a license issued by the home state. 1093 (2) A home state may take adverse action based on the 1094 investigative information of a remote state, so long as the home 1095 state follows its own procedures for imposing adverse action. 1096 (3) The compact does not override a member state’s decision 1097 that participation in an alternative program may be used in lieu 1098 of adverse action and that such participation remain nonpublic 1099 if required by the member state’s laws. Member states must 1100 require licensees who enter any alternative programs in lieu of 1101 discipline to agree not to practice in any other member state 1102 during the term of the alternative program without prior 1103 authorization from such other member state. 1104 (4) A member state may investigate actual or alleged 1105 violations of the laws and rules for the practice of physical 1106 therapy committed in any other member state by a physical 1107 therapist or physical therapist assistant practicing under the 1108 compact who holds a license or compact privilege in such other 1109 member state. 1110 (5) A remote state may do any of the following: 1111 (a) Take adverse actions as set forth in subsection (4) of 1112 Article IV against a licensee’s compact privilege in the state. 1113 (b) Issue subpoenas for both hearings and investigations 1114 which require the attendance and testimony of witnesses and the 1115 production of evidence. Subpoenas issued by a physical therapy 1116 licensing board in a party member state for the attendance and 1117 testimony of witnesses or for the production of evidence from 1118 another party member state must be enforced in the latter state 1119 by any court of competent jurisdiction, according to the 1120 practice and procedure of that court applicable to subpoenas 1121 issued in proceedings pending before it. The issuing authority 1122 shall pay any witness fees, travel expenses, mileage, and other 1123 fees required by the service laws of the state where the 1124 witnesses or evidence is located. 1125 (c) If otherwise permitted by state law, recover from the 1126 licensee the costs of investigations and disposition of cases 1127 resulting from any adverse action taken against that licensee. 1128 (6)(a) In addition to the authority granted to a member 1129 state by its respective physical therapy practice act or other 1130 applicable state law, a member state may participate with other 1131 member states in joint investigations of licensees. 1132 (b) Member states shall share any investigative, 1133 litigation, or compliance materials in furtherance of any joint 1134 or individual investigation initiated under the compact. 1135 1136 ARTICLE VII 1137 ESTABLISHMENT OF THE 1138 PHYSICAL THERAPY COMPACT COMMISSION 1139 1140 (1) COMMISSION CREATED.—The member states hereby create and 1141 establish a joint public agency known as the Physical Therapy 1142 Compact Commission: 1143 (a) The commission is an instrumentality of the member 1144 states. 1145 (b) Venue is proper, and judicial proceedings by or against 1146 the commission must be brought solely and exclusively, in a 1147 court of competent jurisdiction where the principal office of 1148 the commission is located. The commission may waive venue and 1149 jurisdictional defenses to the extent it adopts or consents to 1150 participate in alternative dispute resolution proceedings. 1151 (c) The compact may not be construed to be a waiver of 1152 sovereign immunity. 1153 (2) MEMBERSHIP, VOTING, AND MEETINGS.— 1154 (a) Each member state has and is limited to one delegate 1155 selected by that member state’s physical therapy licensing board 1156 to serve on the commission. The delegate must be a current 1157 member of the physical therapy licensing board who is a physical 1158 therapist, a physical therapist assistant, a public member, or 1159 the board administrator. 1160 (b) A delegate may be removed or suspended from office as 1161 provided by the law of the state from which the delegate is 1162 appointed. Any vacancy occurring on the commission must be 1163 filled by the physical therapy licensing board of the member 1164 state for which the vacancy exists. 1165 (c) Each delegate is entitled to one vote with regard to 1166 the adoption of rules and bylaws and shall otherwise have an 1167 opportunity to participate in the business and affairs of the 1168 commission. 1169 (d) A delegate shall vote in person or by such other means 1170 as provided in the bylaws. The bylaws may provide for delegates’ 1171 participation in meetings by telephone or other means of 1172 communication. 1173 (e) The commission shall meet at least once during each 1174 calendar year. Additional meetings may be held as set forth in 1175 the bylaws. 1176 (f) All meetings must be open to the public, and public 1177 notice of meetings must be given in the same manner as required 1178 under the rulemaking provisions in Article IX. 1179 (g) The commission or the executive board or other 1180 committees of the commission may convene in a closed, nonpublic 1181 meeting if the commission or executive board or other committees 1182 of the commission must discuss any of the following: 1183 1. Noncompliance of a member state with its obligations 1184 under the compact. 1185 2. The employment, compensation, or discipline of, or other 1186 matters, practices, or procedures related to, specific employees 1187 or other matters related to the commission’s internal personnel 1188 practices and procedures. 1189 3. Current, threatened, or reasonably anticipated 1190 litigation against the commission, executive board, or other 1191 committees of the commission. 1192 4. Negotiation of contracts for the purchase, lease, or 1193 sale of goods, services, or real estate. 1194 5. An accusation of any person of a crime or a formal 1195 censure of any person. 1196 6. Information disclosing trade secrets or commercial or 1197 financial information that is privileged or confidential. 1198 7. Information of a personal nature where disclosure would 1199 constitute a clearly unwarranted invasion of personal privacy. 1200 8. Investigatory records compiled for law enforcement 1201 purposes. 1202 9. Information related to any investigative reports 1203 prepared by or on behalf of or for use of the commission or 1204 other committee charged with responsibility for investigation or 1205 determination of compliance issues pursuant to the compact. 1206 10. Matters specifically exempted from disclosure by 1207 federal or member state statute. 1208 (h) If a meeting, or portion of a meeting, is closed 1209 pursuant to this subsection, the commission’s legal counsel or 1210 designee must certify that the meeting may be closed and must 1211 reference each relevant exempting provision. 1212 (i) The commission shall keep minutes that fully and 1213 clearly describe all matters discussed in a meeting and shall 1214 provide a full and accurate summary of actions taken and the 1215 reasons therefor, including a description of the views 1216 expressed. All documents considered in connection with an action 1217 must be identified in the minutes. All minutes and documents of 1218 a closed meeting must remain under seal, subject to release only 1219 by a majority vote of the commission or order of a court of 1220 competent jurisdiction. 1221 (3) DUTIES.—The commission shall do all of the following: 1222 (a) Establish the fiscal year of the commission. 1223 (b) Establish bylaws. 1224 (c) Maintain its financial records in accordance with the 1225 bylaws. 1226 (d) Meet and take such actions as are consistent with the 1227 provisions of the compact and the bylaws. 1228 (4) POWERS.—The commission may do any of the following: 1229 (a) Adopt uniform rules to facilitate and coordinate 1230 implementation and administration of the compact. The rules have 1231 the force and effect of law and are binding in all member 1232 states. 1233 (b) Bring and prosecute legal proceedings or actions in the 1234 name of the commission, provided that the standing of any state 1235 physical therapy licensing board to sue or be sued under 1236 applicable law is not affected. 1237 (c) Purchase and maintain insurance and bonds. 1238 (d) Borrow, accept, or contract for services of personnel, 1239 including, but not limited to, employees of a member state. 1240 (e) Hire employees and elect or appoint officers; fix the 1241 compensation of, define the duties of, and grant appropriate 1242 authority to such individuals to carry out the purposes of the 1243 compact; and establish the commission’s personnel policies and 1244 programs relating to conflicts of interest, qualifications of 1245 personnel, and other related personnel matters. 1246 (f) Accept any appropriate donations and grants of money, 1247 equipment, supplies, materials, and services and receive, use, 1248 and dispose of the same, provided that at all times the 1249 commission avoids any appearance of impropriety or conflict of 1250 interest. 1251 (g) Lease, purchase, accept appropriate gifts or donations 1252 of, or otherwise own, hold, improve, or use any property, real, 1253 personal, or mixed, provided that at all times the commission 1254 avoids any appearance of impropriety or conflict of interest. 1255 (h) Sell, convey, mortgage, pledge, lease, exchange, 1256 abandon, or otherwise dispose of any property, real, personal, 1257 or mixed. 1258 (i) Establish a budget and make expenditures. 1259 (j) Borrow money. 1260 (k) Appoint committees, including standing committees 1261 composed of members, state regulators, state legislators or 1262 their representatives, and consumer representatives, and such 1263 other interested persons as may be designated in the compact and 1264 the bylaws. 1265 (l) Provide information to, receive information from, and 1266 cooperate with law enforcement agencies. 1267 (m) Establish and elect an executive board. 1268 (n) Perform such other functions as may be necessary or 1269 appropriate to achieve the purposes of the compact consistent 1270 with the state regulation of physical therapy licensure and 1271 practice. 1272 (5) THE EXECUTIVE BOARD.— 1273 (a) The executive board may act on behalf of the commission 1274 according to the terms of the compact. 1275 (b) The executive board shall be composed of the following 1276 nine members: 1277 1. Seven voting members who are elected by the commission 1278 from the current membership of the commission. 1279 2. One ex officio, nonvoting member from the recognized 1280 national physical therapy professional association. 1281 3. One ex officio, nonvoting member from the recognized 1282 membership organization of the physical therapy licensing 1283 boards. 1284 (c) The ex officio members shall be selected by their 1285 respective organizations. 1286 (d) The commission may remove any member of the executive 1287 board as provided in its bylaws. 1288 (e) The executive board shall meet at least annually. 1289 (f) The executive board shall do all of the following: 1290 1. Recommend to the entire commission changes to the rules 1291 or bylaws, compact legislation, fees paid by compact member 1292 states, such as annual dues, and any commission compact fee 1293 charged to licensees for the compact privilege. 1294 2. Ensure compact administration services are appropriately 1295 provided, contractually or otherwise. 1296 3. Prepare and recommend the budget. 1297 4. Maintain financial records on behalf of the commission. 1298 5. Monitor compact compliance of member states and provide 1299 compliance reports to the commission. 1300 6. Establish additional committees as necessary. 1301 7. Perform other duties as provided in the rules or bylaws. 1302 (6) FINANCING OF THE COMMISSION.— 1303 (a) The commission shall pay, or provide for the payment 1304 of, the reasonable expenses of its establishment, organization, 1305 and ongoing activities. 1306 (b) The commission may accept any appropriate revenue 1307 sources, donations, and grants of money, equipment, supplies, 1308 materials, and services. 1309 (c) The commission may levy and collect an annual 1310 assessment from each member state or impose fees on other 1311 parties to cover the cost of the operations and activities of 1312 the commission and its staff. Such assessments and fees must 1313 total to an amount sufficient to cover the commission’s annual 1314 budget as approved each year for which revenue is not provided 1315 by other sources. The aggregate annual assessment amount must be 1316 allocated based upon a formula to be determined by the 1317 commission, which shall adopt a rule binding upon all member 1318 states. 1319 (d) The commission may not incur obligations of any kind 1320 before securing the funds adequate to meet such obligations; nor 1321 may the commission pledge the credit of any of the member 1322 states, except by and with the authority of the member state. 1323 (e) The commission shall keep accurate accounts of all 1324 receipts and disbursements. The receipts and disbursements of 1325 the commission are subject to the audit and accounting 1326 procedures established under its bylaws. However, all receipts 1327 and disbursements of funds handled by the commission must be 1328 audited yearly by a certified or licensed public accountant, and 1329 the report of the audit must be included in and become part of 1330 the annual report of the commission. 1331 (7) QUALIFIED IMMUNITY, DEFENSE, AND INDEMNIFICATION.— 1332 (a) The members, officers, executive director, employees, 1333 and representatives of the commission are immune from suit and 1334 liability, whether personally or in their official capacity, for 1335 any claim for damage to or loss of property or personal injury 1336 or other civil liability caused by or arising out of any actual 1337 or alleged act, error, or omission that occurred, or that the 1338 person against whom the claim is made had a reasonable basis for 1339 believing occurred, within the scope of commission employment, 1340 duties, or responsibilities. However, this paragraph may not be 1341 construed to protect any such person from suit or liability for 1342 any damage, loss, injury, or liability caused by the 1343 intentional, willful, or wanton misconduct of that person. 1344 (b) The commission shall defend any member, officer, 1345 executive director, employee, or representative of the 1346 commission in any civil action seeking to impose liability 1347 arising out of any actual or alleged act, error, or omission 1348 that occurred within the scope of commission employment, duties, 1349 or responsibilities, or that the person against whom the claim 1350 is made had a reasonable basis for believing occurred within the 1351 scope of commission employment, duties, or responsibilities. 1352 However, this subsection may not be construed to prohibit any 1353 member, officer, executive director, employee, or representative 1354 of the commission from retaining his or her own counsel or to 1355 require the commission to defend such person if the actual or 1356 alleged act, error, or omission resulted from that person’s 1357 intentional, willful, or wanton misconduct. 1358 (c) The commission shall indemnify and hold harmless any 1359 member, officer, executive director, employee, or representative 1360 of the commission for the amount of any settlement or judgment 1361 obtained against that person arising out of any actual or 1362 alleged act, error, or omission that occurred within the scope 1363 of commission employment, duties, or responsibilities, or that 1364 such person had a reasonable basis for believing occurred within 1365 the scope of commission employment, duties, or responsibilities, 1366 provided that the actual or alleged act, error, or omission did 1367 not result from the intentional, willful, or wanton misconduct 1368 of that person. 1369 1370 ARTICLE VIII 1371 DATA SYSTEM 1372 1373 (1) The commission shall provide for the development, 1374 maintenance, and use of a coordinated database and reporting 1375 system containing licensure, adverse action, and investigative 1376 information on all licensees in member states. 1377 (2) Notwithstanding any other provision of state law to the 1378 contrary, a member state shall submit a uniform data set to the 1379 data system on all individuals to whom the compact is applicable 1380 as required by the rules of the commission, which data set must 1381 include all of the following: 1382 (a) Identifying information. 1383 (b) Licensure data. 1384 (c) Investigative information. 1385 (d) Adverse actions against a license or compact privilege. 1386 (e) Nonconfidential information related to alternative 1387 program participation. 1388 (f) Any denial of application for licensure, and the reason 1389 for such denial. 1390 (g) Other information that may facilitate the 1391 administration of the compact, as determined by the rules of the 1392 commission. 1393 (3) Investigative information in the system pertaining to a 1394 licensee in any member state must be available only to other 1395 party member states. 1396 (4) The commission shall promptly notify all member states 1397 of any adverse action taken against a licensee or an individual 1398 applying for a license in a member state. Adverse action 1399 information pertaining to a licensee in any member state must be 1400 available to all other member states. 1401 (5) Member states contributing information to the data 1402 system may designate information that may not be shared with the 1403 public without the express permission of the contributing state. 1404 (6) Any information submitted to the data system which is 1405 subsequently required to be expunged by the laws of the member 1406 state contributing the information must be removed from the data 1407 system. 1408 1409 ARTICLE IX 1410 RULEMAKING 1411 1412 (1) The commission shall exercise its rulemaking powers 1413 pursuant to the criteria set forth in this article and the rules 1414 adopted thereunder. Rules and amendments become binding as of 1415 the date specified in each rule or amendment. 1416 (2) If a majority of the legislatures of the member states 1417 rejects a rule by enactment of a statute or resolution in the 1418 same manner used to adopt the compact within 4 years after the 1419 date of adoption of the rule, such rule does not have further 1420 force and effect in any member state. 1421 (3) Rules or amendments to the rules must be adopted at a 1422 regular or special meeting of the commission. 1423 (4) Before adoption of a final rule by the commission, and 1424 at least 30 days before the meeting at which the rule will be 1425 considered and voted upon, the commission must file a notice of 1426 proposed rulemaking on all of the following: 1427 (a) The website of the commission or another publicly 1428 accessible platform. 1429 (b) The website of each member state physical therapy 1430 licensing board or another publicly accessible platform or the 1431 publication in which each state would otherwise publish proposed 1432 rules. 1433 (5) The notice of proposed rulemaking must include all of 1434 the following: 1435 (a) The proposed date, time, and location of the meeting in 1436 which the rule or amendment will be considered and voted upon. 1437 (b) The text of the proposed rule or amendment and the 1438 reason for the proposed rule. 1439 (c) A request for comments on the proposed rule or 1440 amendment from any interested person. 1441 (d) The manner in which interested persons may submit 1442 notice to the commission of their intention to attend the public 1443 hearing and any written comments. 1444 (6) Before adoption of a proposed rule or amendment, the 1445 commission must allow persons to submit written data, facts, 1446 opinions, and arguments, which must be made available to the 1447 public. 1448 (7) The commission must grant an opportunity for a public 1449 hearing before it adopts a rule or an amendment if a hearing is 1450 requested by any of the following: 1451 (a) At least 25 persons. 1452 (b) A state or federal governmental subdivision or agency. 1453 (c) An association having at least 25 members. 1454 (8) If a scheduled public hearing is held on the proposed 1455 rule or amendment, the commission must publish the date, time, 1456 and location of the hearing. If the hearing is held through 1457 electronic means, the commission must publish the mechanism for 1458 access to the electronic hearing. 1459 (a) All persons wishing to be heard at the hearing must 1460 notify the executive director of the commission or another 1461 designated member in writing of their desire to appear and 1462 testify at the hearing at least 5 business days before the 1463 scheduled date of the hearing. 1464 (b) Hearings must be conducted in a manner providing each 1465 person who wishes to comment a fair and reasonable opportunity 1466 to comment orally or in writing. 1467 (c) All hearings must be recorded. A copy of the recording 1468 must be made available on request. 1469 (d) This article may not be construed to require a separate 1470 hearing on each rule. Rules may be grouped for the convenience 1471 of the commission at hearings required by this article. 1472 (9) Following the scheduled hearing date, or by the close 1473 of business on the scheduled hearing date if the hearing was not 1474 held, the commission shall consider all written and oral 1475 comments received. 1476 (10) If no written notice of intent to attend the public 1477 hearing by interested parties is received, the commission may 1478 proceed with adoption of the proposed rule without a public 1479 hearing. 1480 (11) The commission shall, by majority vote of all members, 1481 take final action on the proposed rule and shall determine the 1482 effective date of the rule, if any, based on the rulemaking 1483 record and the full text of the rule. 1484 (12) Upon determination that an emergency exists, the 1485 commission may consider and adopt an emergency rule without 1486 prior notice, opportunity for comment, or hearing, provided that 1487 the usual rulemaking procedures provided in the compact and in 1488 this article are retroactively applied to the rule as soon as 1489 reasonably possible, in no event later than 90 days after the 1490 effective date of the rule. For the purposes of this subsection, 1491 an emergency rule is one that must be adopted immediately in 1492 order to do any of the following: 1493 (a) Meet an imminent threat to public health, safety, or 1494 welfare. 1495 (b) Prevent a loss of commission or member state funds. 1496 (c) Meet a deadline for the adoption of an administrative 1497 rule established by federal law or rule. 1498 (d) Protect public health and safety. 1499 (13) The commission or an authorized committee of the 1500 commission may direct revisions to a previously adopted rule or 1501 amendment for purposes of correcting typographical errors, 1502 errors in format, errors in consistency, or grammatical errors. 1503 Public notice of any revisions must be posted on the website of 1504 the commission. The revision is subject to challenge by any 1505 person for a period of 30 days after posting. The revision may 1506 be challenged only on grounds that the revision results in a 1507 material change to a rule. A challenge must be made in writing 1508 and delivered to the chair of the commission before the end of 1509 the notice period. If a challenge is not made, the revision 1510 takes effect without further action. If the revision is 1511 challenged, the revision may not take effect without the 1512 approval of the commission. 1513 1514 ARTICLE X 1515 OVERSIGHT, DISPUTE RESOLUTION, 1516 AND ENFORCEMENT 1517 1518 (1) OVERSIGHT.— 1519 (a) The executive, legislative, and judicial branches of 1520 state government in each member state shall enforce the compact 1521 and take all actions necessary and appropriate to carry out the 1522 compact’s purposes and intent. The provisions of the compact and 1523 the rules adopted pursuant thereto shall have standing as 1524 statutory law. 1525 (b) All courts shall take judicial notice of the compact 1526 and the rules in any judicial or administrative proceeding in a 1527 member state pertaining to the subject matter of the compact 1528 which may affect the powers, responsibilities, or actions of the 1529 commission. 1530 (c) The commission is entitled to receive service of 1531 process in any such proceeding and has standing to intervene in 1532 such a proceeding for all purposes. Failure to provide service 1533 of process to the commission renders a judgment or an order void 1534 as to the commission, the compact, or the adopted rules. 1535 (2) DEFAULT, TECHNICAL ASSISTANCE, AND TERMINATION.— 1536 (a) If the commission determines that a member state has 1537 defaulted in the performance of its obligations or 1538 responsibilities under the compact or the adopted rules, the 1539 commission must do all of the following: 1540 1. Provide written notice to the defaulting state and other 1541 member states of the nature of the default, the proposed means 1542 of curing the default, and any other action to be taken by the 1543 commission. 1544 2. Provide remedial training and specific technical 1545 assistance regarding the default. 1546 (b) If a state in default fails to cure the default, the 1547 defaulting state may be terminated from the compact upon an 1548 affirmative vote of a majority of the member states, and all 1549 rights, privileges, and benefits conferred by the compact may be 1550 terminated on the effective date of termination. A cure of the 1551 default does not relieve the offending state of obligations or 1552 liabilities incurred during the period of default. 1553 (c) Termination of membership in the compact may be imposed 1554 only after all other means of securing compliance have been 1555 exhausted. The commission shall give notice of intent to suspend 1556 or terminate a defaulting member state to the governor and 1557 majority and minority leaders of the defaulting state’s 1558 legislature and to each of the member states. 1559 (d) A state that has been terminated from the compact is 1560 responsible for all assessments, obligations, and liabilities 1561 incurred through the effective date of termination, including 1562 obligations that extend beyond the effective date of 1563 termination. 1564 (e) The commission does not bear any costs related to a 1565 state that is found to be in default or that has been terminated 1566 from the compact, unless agreed upon in writing between the 1567 commission and the defaulting state. 1568 (f) The defaulting state may appeal the action of the 1569 commission by petitioning the United States District Court for 1570 the District of Columbia or the federal district where the 1571 commission has its principal offices. The prevailing member 1572 shall be awarded all costs of such litigation, including 1573 reasonable attorney fees. 1574 (3) DISPUTE RESOLUTION.— 1575 (a) Upon request by a member state, the commission must 1576 attempt to resolve disputes related to the compact which arise 1577 among member states and between member and nonmember states. 1578 (b) The commission shall adopt a rule providing for both 1579 mediation and binding dispute resolution for disputes as 1580 appropriate. 1581 (4) ENFORCEMENT.— 1582 (a) The commission, in the reasonable exercise of its 1583 discretion, shall enforce the compact and the commission’s 1584 rules. 1585 (b) By majority vote, the commission may initiate legal 1586 action in the United States District Court for the District of 1587 Columbia or the federal district where the commission has its 1588 principal offices against a member state in default to enforce 1589 compliance with the provisions of the compact and its adopted 1590 rules and bylaws. The relief sought may include both injunctive 1591 relief and damages. In the event judicial enforcement is 1592 necessary, the prevailing member shall be awarded all costs of 1593 such litigation, including reasonable attorney fees. 1594 (c) The remedies under this article are not the exclusive 1595 remedies of the commission. The commission may pursue any other 1596 remedies available under federal or state law. 1597 1598 ARTICLE XI 1599 DATE OF IMPLEMENTATION OF THE 1600 PHYSICAL THERAPY COMPACT 1601 AND ASSOCIATED RULES; 1602 WITHDRAWAL; AND AMENDMENTS 1603 1604 (1) The compact becomes effective on the date that the 1605 compact statute is enacted into law in the tenth member state. 1606 The provisions that become effective at that time are limited to 1607 the powers granted to the commission relating to assembly and 1608 the adoption of rules. Thereafter, the commission shall meet and 1609 exercise rulemaking powers necessary for the implementation and 1610 administration of the compact. 1611 (2) Any state that joins the compact subsequent to the 1612 commission’s initial adoption of the rules is subject to the 1613 rules as they exist on the date that the compact becomes law in 1614 that state. Any rule that has been previously adopted by the 1615 commission has the full force and effect of law on the day the 1616 compact becomes law in that state. 1617 (3) Any member state may withdraw from the compact by 1618 enacting a statute repealing the same. 1619 (a) A member state’s withdrawal does not take effect until 1620 6 months after enactment of the repealing statute. 1621 (b) Withdrawal does not affect the continuing requirement 1622 of the withdrawing state’s physical therapy licensing board to 1623 comply with the investigative and adverse action reporting 1624 requirements of this act before the effective date of 1625 withdrawal. 1626 (4) The compact may not be construed to invalidate or 1627 prevent any physical therapy licensure agreement or other 1628 cooperative arrangement between a member state and a nonmember 1629 state which does not conflict with the provisions of the 1630 compact. 1631 (5) The compact may be amended by the member states. An 1632 amendment to the compact does not become effective and binding 1633 upon any member state until it is enacted into the laws of all 1634 member states. 1635 1636 ARTICLE XII 1637 CONSTRUCTION AND SEVERABILITY 1638 1639 The compact must be liberally construed so as to carry out 1640 the purposes thereof. The provisions of the compact are 1641 severable, and if any phrase, clause, sentence, or provision of 1642 the compact is declared to be contrary to the constitution of 1643 any party member state or of the United States or the 1644 applicability thereof to any government, agency, person, or 1645 circumstance is held invalid, the validity of the remainder of 1646 the compact and the applicability thereof to any government, 1647 agency, person, or circumstance is not affected thereby. If the 1648 compact is held contrary to the constitution of any party member 1649 state, the compact remains in full force and effect as to the 1650 remaining party member states and in full force and effect as to 1651 the party member state affected as to all severable matters. 1652 Section 11. Paragraph (d) of subsection (3) of section 1653 766.1115, Florida Statutes, is amended to read: 1654 766.1115 Health care providers; creation of agency 1655 relationship with governmental contractors.— 1656 (3) DEFINITIONS.—As used in this section, the term: 1657 (d) “Health care provider” or “provider” means: 1658 1. A birth center licensed under chapter 383. 1659 2. An ambulatory surgical center licensed under chapter 1660 395. 1661 3. A hospital licensed under chapter 395. 1662 4. A physician or physician assistant licensed under 1663 chapter 458. 1664 5. An osteopathic physician or osteopathic physician 1665 assistant licensed under chapter 459. 1666 6. A chiropractic physician licensed under chapter 460. 1667 7. A podiatric physician licensed under chapter 461. 1668 8. A registered nurse, nurse midwife, licensed practical 1669 nurse, or advanced practice registered nurse licensed or 1670 registered under part I of chapter 464 or any facility which 1671 employs nurses licensed or registered under part I of chapter 1672 464 to supply all or part of the care delivered under this 1673 section. 1674 9. A midwife licensed under chapter 467. 1675 10. A health maintenance organization certificated under 1676 part I of chapter 641. 1677 11. A health care professional association and its 1678 employees or a corporate medical group and its employees. 1679 12. Any other medical facility the primary purpose of which 1680 is to deliver human medical diagnostic services or which 1681 delivers nonsurgical human medical treatment, and which includes 1682 an office maintained by a provider. 1683 13. A dentist or dental hygienist licensed under chapter 1684 466. 1685 14. A free clinic that delivers only medical diagnostic 1686 services or nonsurgical medical treatment free of charge to all 1687 low-income recipients. 1688 15. Any other health care professional, practitioner, 1689 provider, or facility under contract with a governmental 1690 contractor, including a student enrolled in an accredited 1691 program that prepares the student for licensure as any one of 1692 the professionals listed in subparagraphs 4.-9. and 13. 1693 1694 The term includes any nonprofit corporation qualified as exempt 1695 from federal income taxation under s. 501(a) of the Internal 1696 Revenue Code, and described in s. 501(c) of the Internal Revenue 1697 Code, which delivers health care services provided by licensed 1698 professionals listed in this paragraph, any federally funded 1699 community health center, and any volunteer corporation or 1700 volunteer health care provider that delivers health care 1701 services. 1702 Section 12. Except as otherwise expressly provided in this 1703 act and except for this section, which shall take effect upon 1704 this act becoming a law, or, if this act fails to become a law 1705 until after June 1, 2025, it shall take effect upon becoming a 1706 law and shall operate retroactively to June 1, 2025, this act 1707 shall take effect July 1, 2025.

Official text from the Florida Legislature. Formatting has been adapted for reading on Ratifi.